Loading...

Nano-X Imaging Ltd.

NNOXNASDAQ
Healthcare
Medical - Devices
$1.73
$0.03(1.76%)
U.S. Market opens in NaNh NaNm

Nano-X Imaging Ltd. Fundamental Analysis

Nano-X Imaging Ltd. (NNOX) shows moderate financial fundamentals with a PE ratio of -1.53, profit margin of -5.76%, and ROE of -47.09%. The company generates $0.0B in annual revenue with strong year-over-year growth of 15.40%.

Key Strengths

Cash Position51.38%
PEG Ratio0.05
Current Ratio3.96

Areas of Concern

ROE-47.09%
Operating Margin-4.66%
We analyze NNOX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -435.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-435.4/100

We analyze NNOX's fundamental strength across five key dimensions:

Efficiency Score

Weak

NNOX struggles to generate sufficient returns from assets.

ROA > 10%
-46.26%

Valuation Score

Excellent

NNOX trades at attractive valuation levels.

PE < 25
-1.53
PEG Ratio < 2
0.05

Growth Score

Moderate

NNOX shows steady but slowing expansion.

Revenue Growth > 5%
15.40%
EPS Growth > 10%
-27.47%

Financial Health Score

Excellent

NNOX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
3.96

Profitability Score

Weak

NNOX struggles to sustain strong margins.

ROE > 15%
-4709.49%
Net Margin ≥ 15%
-5.76%
Positive Free Cash Flow
No

Key Financial Metrics

Is NNOX Expensive or Cheap?

P/E Ratio

NNOX trades at -1.53 times earnings. This suggests potential undervaluation.

-1.53

PEG Ratio

When adjusting for growth, NNOX's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Nano-X Imaging Ltd. at 0.82 times its book value. This may indicate undervaluation.

0.82

EV/EBITDA

Enterprise value stands at -3.28 times EBITDA. This is generally considered low.

-3.28

How Well Does NNOX Make Money?

Net Profit Margin

For every $100 in sales, Nano-X Imaging Ltd. keeps $-5.76 as profit after all expenses.

-5.76%

Operating Margin

Core operations generate -4.66 in profit for every $100 in revenue, before interest and taxes.

-4.66%

ROE

Management delivers $-47.09 in profit for every $100 of shareholder equity.

-47.09%

ROA

Nano-X Imaging Ltd. generates $-46.26 in profit for every $100 in assets, demonstrating efficient asset deployment.

-46.26%

Following the Money - Real Cash Generation

Operating Cash Flow

Nano-X Imaging Ltd. generates limited operating cash flow of $-44.80M, signaling weaker underlying cash strength.

$-44.80M

Free Cash Flow

Nano-X Imaging Ltd. generates weak or negative free cash flow of $-49.42M, restricting financial flexibility.

$-49.42M

FCF Per Share

Each share generates $-0.71 in free cash annually.

$-0.71

FCF Yield

NNOX converts -39.84% of its market value into free cash.

-39.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.53

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.82

vs 25 benchmark

P/S Ratio

Price to sales ratio

9.17

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.47

vs 25 benchmark

ROA

Return on assets percentage

-0.46

vs 25 benchmark

ROCE

Return on capital employed

-0.42

vs 25 benchmark

How NNOX Stacks Against Its Sector Peers

MetricNNOX ValueSector AveragePerformance
P/E Ratio-1.5328.65 Better (Cheaper)
ROE-47.09%795.00% Weak
Net Margin-576.13%-49787.00% (disorted) Weak
Debt/Equity0.060.40 Strong (Low Leverage)
Current Ratio3.963.73 Strong Liquidity
ROA-46.26%-20255.00% (disorted) Weak

NNOX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nano-X Imaging Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

5.10%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

-4.47%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ